Preventing Atrial Fibrillation After Cardiac Surgery A New Method Using an Old Tool

摘要

Atrial fibrillation (AF) after cardiac surgery remains a common problem, resulting in prolonged hospital stays and added morbidity for a substantial proportion of patients.1 Although traditional therapies with antiarrhythmic agents can suppress this common arrhythmia in nearly half of all cases, generally >1 in 10 of all cardiac surgery patients will have AF despite the best available therapies, and amiodarone, the most potent conventional agent, carries the risk of numerous toxicities#